Pfizer (PFE) Crashes

Large-cap Healthcare company Pfizer has moved -4.6% so far today on a volume of 20,496,616, compared to its average of 20,769,225. In contrast, the S&P 500 index moved 0.2%.

If you are considering an investment in PFE, you'll want to know the following:

  • Pfizer's current price is 81.2% above its Graham number of $26.8, which implies that at its current valuation it does not offer a margin of safety

  • Based on its trailing earnings per share of 1.71, Pfizer has a trailing 12 month Price to Earnings (P/E) ratio of 28.4 while the S&P 500 average is 15.97

  • PFE has a forward P/E ratio of 15.4 based on its forward 12 month price to earnings (EPS) of $3.16 per share

  • Its Price to Book (P/B) ratio is 4.3 compared to its sector average of 4.07

  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

  • Based in New York, the company has 79,000 full time employees and a market cap of $272,564,338,688. Pfizer currently returns an annual dividend yield of 3.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.